Aromazin (exemestane) tablets 25 mg. №30


Manufacturer: Italy



Advantageous therapy for women with invasive breast cancer of early stages with a positive breakdown at the estrogen receptor at the postmenopausal period of 2-3 postpartum admission therapy with juvenile therapy with tamoxifen.
Like widespread breast cancer in women with natural and post-menopausal status, in some of them there is a manifestation of the progression of twigs with anti-estrogen therapy. Efficiency in patients with negative breakdown at estrogen receptors was not demonstrated in Bula.